Shares of Catalyst Pharmaceuticals (CPRX) rose by a staggering 26.96% in 30 days from $4.34 to $5.51 at 21:12 EST on Saturday, after two successive sessions in a row of gains. NASDAQ Composite (CPRX) is rising 2.32% to $13,429.98, after two sequential sessions in a row of gains.

Catalyst Pharmaceuticals’s last close was $4.98, 6.17% under its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 3%, now sitting on 119.07M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.51 at 21:12 EST, higher than its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way above its 50-day moving average of $4.11 and way above its 200-day moving average of $3.63.

More news about Catalyst Pharmaceuticals (CPRX).

LEAVE A REPLY

Please enter your comment!
Please enter your name here